Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Voyager Therapeutics (VYGR) Change in Acquisitions & Divestments (2016 - 2025)

Historic Change in Acquisitions & Divestments for Voyager Therapeutics (VYGR) over the last 9 years, with Q1 2025 value amounting to $118.8 million.

  • Voyager Therapeutics' Change in Acquisitions & Divestments rose 805.53% to $118.8 million in Q1 2025 from the same period last year, while for Mar 2025 it was $286.3 million, marking a year-over-year increase of 4680.12%. This contributed to the annual value of $374.3 million for FY2024, which is 33741.84% up from last year.
  • Per Voyager Therapeutics' latest filing, its Change in Acquisitions & Divestments stood at $118.8 million for Q1 2025, which was up 805.53% from $109.9 million recorded in Q1 2024.
  • Voyager Therapeutics' 5-year Change in Acquisitions & Divestments high stood at $118.8 million for Q1 2025, and its period low was $22.6 million during Q2 2021.
  • Over the past 3 years, Voyager Therapeutics' median Change in Acquisitions & Divestments value was $72.5 million (recorded in 2021), while the average stood at $71.6 million.
  • Within the past 5 years, the most significant YoY rise in Voyager Therapeutics' Change in Acquisitions & Divestments was 5088.0% (2021), while the steepest drop was 6832.58% (2021).
  • Over the past 3 years, Voyager Therapeutics' Change in Acquisitions & Divestments (Quarter) stood at $22.6 million in 2021, then soared by 385.72% to $109.9 million in 2024, then increased by 8.06% to $118.8 million in 2025.
  • Its Change in Acquisitions & Divestments stands at $118.8 million for Q1 2025, versus $109.9 million for Q1 2024 and $22.6 million for Q2 2021.